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Research
Harmful algal blooms (HABs) of Karenia 
brevis, a marine dinoflagellate, occur almost 
annually in the Gulf of Mexico off the 
west coast of Florida (Heil and Steidinger 
2009). K. brevis cells produce potent poly­
ether neuro toxins known as brevetoxins 
(Baden et al. 1995; Poli et al. 1986), which 
are released into the ocean when the cells are 
lysed by wind and waves (Pierce et al. 2001). 
At high concentrations, K. brevis blooms may 
cause mortality of fish, marine mammals, and 
sea birds. Humans who consume shellfish 
contaminated with brevetoxins are at high 
risk of developing neuro toxic shellfish poison­
ing (NSP) (Watkins et al. 2008). Further, 
there have been anecdotal reports of skin ail­
ments resulting from contact with brevetoxin­
contaminated water (Kirkpatrick et al. 2004). 
HAB cell count generally correlates with 
brevetoxin concentration, and residual breve­
toxins in seawater have been observed after 
blooms have diminished (Pierce RH, personal 
communication). Bubbles from breaking 
waves transport brevetoxins to the sea sur­
face, where they may be released to the air as 
jet drops when the bubbles burst (Blanchard 
1989; Pierce et al. 1990, 2003). In the air, 
brevetoxins become incorporated into marine 
aerosols, which are built around charged salt 
particles. Aerosol transport is highly influenced 
by wind speed and direction, and aerosolized 
brevetoxins can travel as much as 1 mile inland 
(Fleming et al. 2005; Kirkpatrick et al. 2008). 
Woodcock (1948) reported the first 
accounts of respiratory irritation in humans 
during severe red tide (HAB) conditions on 
the Florida Gulf Coast. Subsequent studies 
have linked inhalation of aerosolized breve­
toxins with adverse health effects, including 
rhinorrhea, non productive cough, and severe 
broncho constriction (Asai et al. 1982; Backer 
et al. 2003; Cheng et al. 2005; Fleming et al. 
2005, 2007; Kirkpatrick et al. 2004, 2001; 
Music et al. 1973). Epidemiologic studies, 
animal experiments, and anecdotal reports 
now suggest that aerosolized brevetoxins are 
linked to both upper and lower respiratory ill­
nesses in humans (Backer et al. 2003; Fleming 
et al. 2005, 2007; Kirkpatrick et al. 2004). In 
addition to significantly increased respiratory 
symptoms, asthmatic individuals have shown 
small but statistically significant changes in 
lung function immediately after 1­hr visits 
to the beach during Florida blooms (Backer 
and McGillicuddy 2006; Fleming et al. 2005, 
2007). After only 1 hr of exposure to aero­
sols at the beach, respiratory complaints may 
last up to 5 days in asthmatics (Kirkpatrick 
et al. 2008). Finally, research using data for 
respiratory visits to the emergency department 
(ED) demonstrated a significantly increased 
risk of visits for pneumonia, bronchitis, and 
asthma during a Florida red tide period com­
pared with a similar period without red tide 
(Kirkpatrick et al. 2006). This risk is particu­
larly relevant for coastal residents. 
In the present study we assessed the relation­
ship between K. brevis blooms and respiratory 
illness­related visits to hospital EDs while con­
trolling for environmental factors and disease 
that also may function as significant risk factors 
for respiratory ailments. Further, we developed 
estimates of the costs of illness resulting from 
medical treatments for acute brevetoxin­related 
respiratory illnesses. This work is an important 
step toward understanding one component of 
the economic effects of K. brevis blooms. It may 
help guide the selection and implementation of 
management actions to mitigate public health 
effects and illness costs for brevetoxins and possi­
bly other HABs. Further, it may provide insight 
to health care administrators and providers as to 
human resource and medical supply needs as a 
result of K. brevis blooms.
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Background: Algal blooms of Karenia brevis, a harmful marine algae, occur almost annually off 
the west coast of Florida. At high concentrations, K. brevis blooms can cause harm through the 
release of potent toxins, known as brevetoxins, to the atmosphere. Epidemiologic studies suggest 
that aerosolized brevetoxins are linked to respiratory illnesses in humans.
oBjectives: We hypothesized a relationship between K. brevis blooms and respiratory illness visits 
to hospital emergency departments (EDs) while controlling for environmental factors, disease, and 
tourism. We sought to use this relationship to estimate the costs of illness associated with aero-
solized brevetoxins. 
Methods: We developed a statistical exposure–response model to express hypotheses about the 
relationship between respiratory illnesses and bloom events. We estimated the model with data on 
ED visits, K. brevis cell densities, and measures of pollen, pollutants, respiratory disease, and intra-
annual population changes. 
results: We found that lagged K. brevis cell counts, low air temperatures, influenza outbreaks, high 
pollen counts, and tourist visits helped explain the number of respiratory-specific ED diagnoses. The 
capitalized estimated marginal costs of illness for ED respiratory illnesses associated with K. brevis 
blooms in Sarasota County, Florida, alone ranged from $0.5 to $4 million, depending on bloom 
severity. 
conclusions: Blooms of K. brevis lead to significant economic impacts. The costs of illness of ED 
visits are a conservative estimate of the total economic impacts. It will become increasingly necessary 
to understand the scale of the economic losses associated with K. brevis blooms to make rational 
choices about appropriate mitigation.
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materials and methods
Methods. Aerosolized brevetoxins may result 
in respiratory illnesses of varying severities. 
Many individuals with respiratory symptoms 
caused by brevetoxins may respond initially 
by purchasing over­the­counter medicines or 
taking time off from work or leisure. At pres­
ent, data on visits to physicians and out patient 
facilities are unavailable for unreported dis­
ease. For low­severity illnesses, medical costs 
are uncertain but are expected to be minor 
and unlikely to involve significant productiv­
ity losses. In this study, we focused on visits 
to EDs for which we have credible data. There 
also may be cases of further hospitalizations or 
mortalities, but we expect that the number of 
patients experiencing these severities is small. 
In particular, we are unaware of any deaths 
caused by aerosolized brevetoxins. 
We focused on the relationship between 
HAB cell counts and respiratory hospital ED 
visits from 2001 to 2006 in Sarasota, Florida. 
Sarasota experiences nearshore K. brevis 
blooms on an almost annual basis; in some 
years, there are multiple or even continuous 
blooms. These events have been documented 
through monitoring efforts by researchers at 
Mote Marine Laboratory (MML). We focused 
on Sarasota Memorial Hospital (SMH), the 
hospital located closest to the coastline of the 
four hospitals in Sarasota County. SMH is the 
largest acute­care facility in Sarasota County, 
serving 63.3% of the county’s population 
(Kirkpatrick et al. 2006). 
In our analysis we concentrated on two 
main types of respiratory conditions: all respi­
ratory diseases taken together and a combi­
nation of upper airway disease (UAD) and 
chronic/acute bronchitis. Previous work by 
Kirkpatrick et al. (2006) demonstrated that 
UAD and bronchitis (as well as pneumonia 
and asthma) are particularly likely to be exac­
erbated by aerosolized brevetoxins. Adverse 
respiratory conditions may be attributable to 
HABs or a combination of HABs with other 
ambient factors. 
We developed an exposure–response model 
to express hypotheses about the relationship 
between respiratory illnesses, HAB events, 
and other potential explanatory variables. The 
model is formulated as follows:
 EDt = f (Ht–1,Wt,Dt,Tt,εt),  [1]
where the subscript t indexes the relevant 
week; ED is a measure of the number of respi­
ratory illness ED visits at SMH; H is a lagged 
measure of in situ K. brevis cell counts near the 
Sarasota coast; W is a vector of environmental 
and weather conditions; D is a meas ure of 
regional respiratory disease outbreaks; and T is 
a measure of tourist visits to Sarasota County. 
Equation 1 is estimated using auto regressive 
error models. 
Data. We investigated a large number 
of environmental, disease, and tourism vari­
ables (Polansky et al. 2007). We present two 
parsimonious models here. Variables inves­
tigated but not included in the final model 
specifications are mentioned briefly below. 
Descriptive statistics for model variables 
appear in Table 1. 
The total number of daily SMH ED vis­
its for respiratory diagnoses were compiled 
from October 2001 through September 2006. 
Access to anonymous medical data was pro­
vided by SMH after its Institutional Review 
Board’s approval of the use of data for our 
study. Using codes from the International 
Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD­9­CM), these 
diagnoses were categorized as respiratory ill­
nesses (e.g., pneumonia, bronchitis, asthma, 
UAD) or all other primary diagnoses (NCHS 
2009). We calculated for each week the daily 
average number of ED visits for two catego­
ries of respiratory diagnoses (all four diseases 
and a combined UAD/bronchitis).
In situ K. brevis cell counts served as a 
proxy for aerosolized brevetoxin concentra­
tions along the coast. Cheng et al. (2005) 
developed an empirical relationship between 
brevetoxin concentration in the ocean and in 
the atmosphere as a function of wind speed 
and wind direction. Aerosolized breve toxins 
have been measured as much as 1 mile inland 
from the coast (Kirkpatrick et al. 2008); thus, 
the affected population may include those who 
are not right on the coast or do not visit the 
beach or shoreline. Measurements of breve­
toxin concentrations in the ocean are time 
consuming and costly to make. Consequently, 
long­term brevetoxin concentration data sets 
are unavailable. We assumed that because 
higher HAB cell counts would yield increased 
breve toxin concentrations in water, and sub­
sequently in air, they were a reasonable proxy 
for aerosolized toxin.
K. brevis cell counts were sampled at two 
Sarasota Bay locations [New Pass (27.19°N, 
82.34°W) and the MML Bay Dock (27.33°N, 
82.58°W)]. Water samples were analyzed 
weekly during non bloom conditions and daily 
during blooms. We averaged the data from 
both sampling stations to obtain a measure of 
in situ cell count. To create a consistent data set, 
we compiled for each week the daily average of 
K. brevis cell counts across both sampling sta­
tions. Because of the large range of cell counts, 
we transformed the data for scale purposes. The 
HAB measure we employed in the model is the 
square root of one­thousandth of the weekly 
average of daily average K. brevis cell counts. 
Pierce et al. (2001) determined that toxins 
are released into the water as cells rupture, 
thereby increasing the amount of extra cellular 
toxins as a bloom progresses. After release into 
marine waters, the toxin subsequently may 
become aerosolized and transported by winds 
onshore, where humans may be exposed 
(Pierce et al. 2003). We expected to find a 
lag between the detection of cells in offshore 
waters and onshore aerosolized brevetoxin 
exposures because of the time required for 
intra­ and extra cellular brevetoxin metabo­
lism and transformation, as well as subsequent 
aeolian transport. A latency period associated 
Table 1. Descriptive statistics for model variables. 
Variable Description Mean ± SD Minimum Maximum
lnEDtott Natural logarithm of the daily average visits per 
week to SMH ED for respiratory ailments (visits)
2.40 ± 0.35 1.69 3.29
lnEDubt Natural logarithm of the daily average visits per 
week to SMH ED for bronchitis and UAD (visits)
2.11 ± 0.37 1.35 3.15
HABt–1 Prior week’s transformed in situ cell count 
(square root of HAB cells × 10–3)
8.11 ± 18.87 0.00 136.39
Tempt Average weekly air temperature (°C) 23.08 ± 4.72 8.41 29.77
Tempt–1 Prior week’s average weekly air temperature (°C) 23.07 ± 4.72 8.41 29.77
Flut Weekly percentage of specimens testing positive 
for influenza in the CDC South Atlantic Region
6.34 ± 9.53 0.00 42.59 
Pollent Weekly transformed total pollen count (square 
root of pollen grains/m3 air × 10–2)
1.10 ± 1.20 0.24 6.55
Touristt Estimated weekly transformed number of tourists 
to Sarasota County (persons × 10–4)
2.14 ± 0.38 1.30 2.98
Table 2. Parameter estimates for Yule-Walker 
autoregression models. 
 Model I Model II
Dependent variable lnEDtot lnEDub
Intercept 2. 9169 2.6328
 (17.76)# (14.38)#
HABt–1 0.0012 0.0019
 (1.81)* (2.54)#
Tempt –0.0120 –0.0107
 (–2.60)# (–2.05)**
Tempt–1 –0.0241 –0.0277
 (–5.06)# (–5.17)#
Flut 0.0096 0.0103
 (4.03)# (3.89)#
Pollent 0.0286 0.0319
 (1.66)* (1.64)*
Touristt 0.1003 0.1161
 (1.89)* (1.95)*
Observations (n) 261 261
DW 1.96 1.96
R 2 0.76 0.74
DW, Durbin-Watson test statistic. t-Values are shown in 
parentheses. 
*p < 0.1. **p < 0.05. #p < 0.01. 
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with the observed health effects of K. brevis 
blooms has not been established, however. 
In the model, we tested for a 1­week lag for 
the in situ HAB cell count. We were unable 
to find correlations between ED visits and 
measures of wind speed, wind direction, or 
wind velocity.
Information on air temperature was col­
lected from a monitor at the MML New 
Pass Weather Station, located at 27.19°N, 
82.34°W (MML 2009). We expected lower 
temperatures would increase the susceptibility 
of individuals to respiratory illnesses, possibly 
with a lagged effect. We compiled the data as 
a weekly average temperature (°C). We were 
unable to find correlations between ED visits 
and a measure of relative humidity. 
Pollen is a common allergen that can 
produce histaminergic responses in sensitive 
individuals, exacerbating existing respiratory 
conditions or initiating new ones (Andersson 
et al. 2003; Atkinson and Strachan 2004; 
Burge and Rogers 2000). Daily pollen counts 
(pollen grains per cubic meter of air) were pro­
vided by the National Allergy Bureau (Jelks 
M, personal communication). Counts were 
obtained using a Burkard 7­day pollen collec­
tor at the regional sampling station, located 
approxi mately 160 miles northeast of Sarasota 
at the University of Florida in Gainesville. 
Counts are given as the square root of pollen 
grains per cubic meter of air × 10–2. We also 
investigated mold counts and local pollution 
measures (ozone, two sizes of airborne particu­
lates, forest fires, and acres of forest burned). 
None of these variables were found to correlate 
with ED visits.
Weekly influenza virus outbreak data for 
the South Atlantic Region were compiled 
by the U.S. Centers for Disease Control and 
Prevention (CDC). These data are a measure 
of the percentage of specimens testing posi­
tive for influenza within a particular week, as 
measured by the World Health Organization 
and the National Respiratory and Enteric 
Virus Surveillance System laboratories. Data 
were provided from October through May 
(weeks 40 through 52 or 53 and weeks 1–20), 
as this time frame is known to correspond 
to epidemic periods (Simonsen et al. 1997). 
The CDC does not track influenza during 
minimal outbreak periods (weeks 21–39). 
We assumed that these gaps in the data cor­
respond to periods of little or no influenza 
cases, and we replaced them with zeroes. 
We obtained data on Sarasota County 
monthly hotel/motel occupancy rates for 
October 2001–September 2006 and the 
number of units by lodging type (e.g., hotel/
motel, campsite, mobile home, apartment, 
condominium, house) from the Sarasota 
Convention and Visitors Bureau (Haley V, 
personal communication). We assumed that 
the percent occupancy of all lodging types 
approximates that of hotels/motels. We 
derived a total number of occupants by lodg­
ing type by making the assumptions of two 
people per hotel/motel, condominium, or 
apartment unit and four people per camp­
site, mobile home, or house. We obtained 
a monthly estimate of the temporary resi­
dent population by summing the number of 
occupants in all units. The tourism variable 
is measured as persons × 10–4. Note that the 
weekly estimates used in the models remained 
constant for the weeks within each month. 
Results
Exposure–response model. Table 2 presents 
Yule­Walker estimates of two different auto­
regressive error models corrected for third­
order auto correlation. Each model considers 
a different dependent variable. In model I, the 
dependent variable is the natural logarithm 
of SMH ED visits for all respiratory ailments 
(lnEDtot). In model II, the dependent variable 
is the natural logarithm of SMH ED visits for 
the combination of UAD/bronchitis (lnEDub). 
Note that the latter measure is included in the 
former, which also includes ED visits due to 
pneumonia and asthma. 
All parameter estimates have the expected 
signs and are significant at the 10% level or 
better in both models. The model results show 
that ED visits for respiratory ailments are 
correlated with lagged K. brevis cell counts, 
regional pollen counts, regional influenza 
outbreaks, and Sarasota County tourist vis­
its, and inversely correlated with temperature 
and temperature lagged 1 week. Both models 
explained about three­fourths of the varia­
tion in their respective dependent variables. 
Figure 1A illustrates how well the model pre­
dicts ED visits compared with the actual data. 
The marginal effects (the incremental change 
in ED visits with an incremental change in 
the variable of interest) and the elasticities 
(percentage change in ED visits with a per­
centage change in the variable of interest) are 
shown in Table 3. Both measures reveal the 
importance of temperature and tourist num­
bers as predictors of ED visits. 
The inverse relationship between tempera­
ture and respiratory ED visits may result from 
the interaction of other agents responsible 
for respiratory ailments (e.g., bacteria and 
viruses). Like influenza, these triggers tend 
to affect more individuals when low ambient 
temperatures prevail (Simonsen et al. 1997). 
Importantly, our measure of aerosolized 
brevetoxins is a significant predictor of ED 
visits for respiratory ailments. Figure 1B 
depicts the number of SMH UAD/bronchitis 
ED visits due to K. brevis blooms predicted by 
model II. Because of variable transformations, 
the parameter value cannot be interpreted 
per se as the marginal effect of changes in cell 
counts on ED visits. The marginal effect is 
itself a function of the cell count, and there­
fore its value will depend on the state of a 
K. brevis bloom. 
In Table 4, we present model predictions 
of yearly ED visits for three different bloom 
levels: low, medium, and high. The 4­year 
period from October 2001 to December 2004 
Figure 1. Weekly ED visits for UAD and bronchitis. (A) Number of actual SMH ED visits in each week for 
UAD and bronchitis and the predicted number of visits for the same illnesses using model II. (B) Number of 
ED visits in each week for the same illnesses predicted to have been caused by brevetoxin exposure. 
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Table 3. Marginal effects and elasticities of model II 
variables (all effects and elasticities taken at the 
means of model variables).
 Marginal effects Elasticities
HABt–1 0.02 0.01
Tempt –0.09 –0.24
Tempt–1 –0.23 –0.61
Flut 0.09 0.06
Pollent 0.26 0.03
Touristt 0.96 0.24
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and January 2006 to September 2006 was used 
for the low­level estimate. The entire 5­year 
data set from October 2001 to September 
2006 was used for the medium­level estimate. 
The period from January 2005 to December 
2005 (a period with a major K. brevis bloom) 
was used for the high­level estimate. We pres­
ent 5­year predictions of ED visits as well, rep­
resenting the potential number of cases should 
bloom levels persist for the relevant level. 
Referring to the results of model II in 
Table 4, the model’s predictions yield annual 
estimates of the likely number of ED visits 
for low (39 visits), mean (76 visits), and high 
(218 visits) bloom levels in Sarasota County. 
We developed our estimates using data for 
SMH, which treats 63.3% of the patients in 
Sarasota County. We have adjusted the esti­
mates for Sarasota County accordingly. These 
estimates are made holding all other model 
variables constant at their respective means. 
Cost-of-illness estimates. A measure of the 
economic impact of respiratory illnesses caused 
by aerosolized brevetoxins is the sum of the 
costs of medical services and lost productivities 
during the illness period. When considering the 
costs of a specific illness, especially one that does 
not involve unusual technologies, treatments, or 
medical skills and one that does not comprise a 
large portion of the total number of visits, esti­
mates of the marginal costs of treatment are 
appropriate. In the case of respiratory ailments 
that are the consequence of exposure to aero­
solized breve toxins, the additional admissions 
per week (on average only 1.5% of the total) are 
unlikely to lead to the need to expand capacity 
in respiratory ED services at SMH. 
In many cases, hospitals must charge 
patients more than average or marginal costs 
for specific medical services. The excess of 
charges over costs is generally used to cover 
the burden to a hospital of the provision of 
medical services that go unpaid because of the 
lack of insurance coverage or the inability or 
unwillingness of patients to pay for treatment. 
Hospitals often cross­subsidize medical services 
within their facilities using the net revenues of 
services with a high inelasticity of demand, 
such as emergency services, to subsidize those 
important services that may have a more elastic 
demand or a lower net revenue margin. Cost­
of­illness estimates based on average charges 
likely exaggerate the true costs of ED visits. 
In the present study, we applied an estimate 
of the ratio of marginal to average charges for 
general ED visits to approximate the marginal 
costs of ED visits for respiratory ailments due 
to aerosolized brevetoxins.
Williams (1996) studied the costs of ED 
visits in six Michigan community hospitals 
and developed estimates of both average and 
marginal costs of ED visits. The author esti­
mated the marginal costs of ED visits for three 
different illness severities: $24 for non urgent 
treatments, $67 for semi urgent treatments, 
and $148 for urgent treatments. Marginal costs 
averaged only about 23% of average costs. 
The Florida Agency for Health Care 
Administration (AHCA) compiles data on 
charges levied by Florida hospitals for indi­
vidual and total medical services for primary 
diagnosed illnesses. Most of the charges for 
UAD/bronchitis illnesses involve emergency 
treatments, radiology services, and laboratory 
tests. Focusing on the relevant ICD­9­CM 
codes for UAD/bronchitis illnesses, we calcu­
lated the 25th and 75th percentile estimates 
for the total ED visit charges and found that 
they ranged from $252 to $1,045 per visit. 
We applied the Williams (1996) ratio of mar­
ginal to average costs of 23% to calculate a 
range of marginal charges from the AHCA 
data of $58–$240 as our preferred range of 
marginal cost estimates.
Where illnesses are severe enough to result 
in lost time at work or lost leisure opportu­
nities, an estimate of the cost of illness also 
should include an estimate of lost productiv­
ity. We assumed that individuals valued their 
leisure time at the margin at approximately 
the same rate as their employment wages. We 
used annual median personal income in 2006 
as a measure of lost productivity (U.S. Census 
Bureau 2008). This measure was converted 
into daily median personal income. 
There are few extant estimates of the 
total number of days of lost productivity to a 
patient as a consequence of a respiratory illness 
treated at an ED. The effects of severe asth­
matic attacks could incapacitate a patient for 
weeks or even months [National Heart, Lung, 
and Blood Institute (NHLBI) 2007]. Even so, 
Rodrigo et al. (2004) relied on a British study 
(Hoskins et al. 2000) that estimated that indi­
rect costs (lost productivities) accounted for 
only 10% of the costs of asthma illnesses. Here 
we refer to the U.S. and British guidelines for 
the treatment of moderate asthma illnesses 
(British Thoracic Society 2008; NHLBI 2007), 
potentially requiring an ED visit. These guide­
lines suggest, on average, 1 day for treatment 
and up to 2 days for recuperation, for a total of 
3 days of lost productivity per illness. 
The population that is adversely affected 
by aerosolized brevetoxins is composed of 
Florida residents as well as tourists or longer­
term visitors (snowbirds) from other states and 
other countries. The AHCA compiles data on 
the state of residence of patients visiting the 
SMH ED for respiratory ailments. We used 
the residential distribution of these patients 
to weight annual median personal income by 
state to determine a weighted average median 
personal income of $38,589. Three days of 
lost productivity therefore has an estimated 
value of approximately $335 (2008 dollars). 
In Table 5, we calculated ranges of costs of 
illness for Sarasota County and for the Florida 
Gulf Coast. We used the predicted number 
of ED visits from model II in combination 
with the range of marginal costs of ED respira­
tory visits for UAD/bronchitis illnesses from 
the AHCA data. We estimated annual costs, 
5­year costs, and capitalized costs using a dis­
count rate of 3%. We chose this discount rate 
as reflective of the historical rate of return on a 
safe asset, such as medium­term government 
bonds. The latter two estimates imply that the 
low­, medium­, or high­bloom levels persist 
during the period of interest. We found that 
the capitalized costs of illness can range from 
$0.5 to $4 million in Sarasota County alone. 
We expect that the costs of illness should be 
much greater for the entire Florida Gulf Coast. 
Discussion
We investigated whether HABs can explain 
respiratory ED visits while controlling for 
relevant environmental factors that also may 
explain these visits. We found that K. brevis 
cell counts (lagged 1 week), low temperatures, 
a high incidence of influenza outbreaks, high 
pollen levels, and large numbers of tourist 
visits (including the snowbirds) all explained 
the number of respiratory­specific ED diagno­
ses. An individual’s ED visit also could be the 
result of multi day exposure to numerous, inter­
acting conditions (e.g., aerosolized brevetoxins 
combined with environmental particulates, 
disease, local weather conditions) rather than 
the influence of one factor over a short time 
period. Statistical tests of our data failed to 
identify such inter actions, however, suggesting 
an avenue for future research.
Table 5. Annual cost-of-illness estimates for Sarasota County (2008 $, millions).a
 Low Medium High
Annual ($) 0.02–0.02 0.03–0.04 0.09–0.13
5-Year ($) 0.08–0.11 0.15–0.22 0.43–0.63
Capitalized [at 3% ($)] 0.52–0.76 1.00–1.45 2.86–4.18
aUsing low, medium, and high predicted ED visits from model II for Sarasota County and the 25th and 75th quartiles of 
estimated marginal costs from the AHCA data for 2005. 
Table 4. Sarasota County ED visits due to K. Brevis blooms (model II).
 Low Medium High
Annual average  39 76 218
5-Year estimate 197 376 1,090
Costs of K. brevis respiratory illnesses
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Analysis of our data revealed that ED visits 
for UAD and bronchitis are explained by the 
K. brevis cell count, but ED visits for pneumo­
nia and asthma are not. However, Asai et al. 
(1982) observed that 80% of the 15 asthmatic 
patients exposed to red tide aerosols at the 
beach complained of asthma attacks, and, more 
recently, Fleming et al. (2005, 2007) found 
statistically significant changes in respiratory 
function in asthmatic residents of Sarasota after 
spending only 1 hr at a Florida beach dur­
ing a red tide. One explanation for our find­
ing is that asthmatics may be conditioned to 
recognize their symptoms, responding with 
pre existing prescriptions, over­the­counter 
medications, or outpatient doctor visits, instead 
of visits to the ED.
Estimates of the costs of illness are only one 
component of the total economic impact of 
K. brevis blooms along the Florida Gulf Coast. 
Notably, other costs of illness relating to illness 
severities and different effects, such as shellfish 
poisoning, are likely to exist. Additional costs 
may be associated with accessing primary care 
physicians, allergists, or pulmonologists, as well 
as prescriptions and over­the­counter medi­
cations. These data were unavailable for this 
study, however. Although there is no obvious 
evidence of mortalities as a consequence of 
respiratory disease, chronic respiratory prob­
lems may be triggered or exacerbated by aero­
solized breve toxins. Here, we did not attempt 
to estimate the costs of additional medi­
cal services required to treat chronic illness. 
Consequently, our cost­of­illness estimates 
should be considered conservative.
Further, we did not account for the non­
market costs associated with pain and suffer­
ing when an individual experiences respiratory 
problems. When a bloom occurs, people often 
avoid visiting the beach; thus, additional non­
market economic losses are associated with 
this behavior. Morgan et al. (2009) recently 
measured economic impacts in the coastal 
restaurant trade during HAB events and indi­
cated that other tourism­related losses, such as 
declines in snowbird visits, could have broader 
impacts on the regional economy. 
As the human migration to the coast of 
the Gulf of Mexico shows little evidence of 
abating, it will be necessary to consider alterna­
tive means of mitigating the public health and 
economic impacts of this natural hazard. It is 
unclear at this juncture whether human activi­
ties have contributed to the observed increase 
in frequency and intensity of K. brevis blooms 
(cf., Gilbert et al. 2005). Preliminary mitiga­
tion strategies involve risk communication 
(poison information center hotlines, signage, 
informational brochures and materials), natural 
resource management (shellfish bed closures), 
and nutrient controls (municipal fertilizer ordi­
nances). All of these strategies entail costs. 
Conclusions
We found that the number of respiratory­
specific ED diagnoses at SMH for UAD/bron­
chitis were correlated with lagged K. brevis 
cell counts, low air temperatures, influenza 
outbreaks, high pollen counts, and tourist 
visits. Extrapolating to Sarasota County, we 
estimated that the capitalized costs of illness 
for ED respiratory illnesses associated with 
K. brevis blooms in Sarasota County alone 
ranged from $0.5 to $4 million. The costs of 
illness of ED visits are a conservative estimate 
of the total economic impacts of K. brevis 
blooms in Sarasota County and for the Florida 
Gulf Coast. Because this is only a portion of 
the total economic impact of these events, it 
will become increasingly necessary to under­
stand the full scale of the economic losses asso­
ciated with K. brevis blooms in order to make 
rational choices about appropriate mitigation.
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